Healthcare Industry News: neuromodulation
News Release - October 7, 2008
St. Jude Medical Celebrates the 50th Anniversary of the World's First Implantable PacemakerST. PAUL, Minn.--(HSMN NewsFeed)--St. Jude Medical, Inc. (NYSE: STJ ) today celebrates the 50th anniversary of the world’s first implantable pacemaker. On Oct. 8, 1958, a Swedish man named Arne Larsson received the world’s first implanted pacemaker. The groundbreaking technology for the implantable cardiac pacemaker was developed by Rune Elmqvist, M.D., of the Swedish company Elema Schönander, which eventually became part of St. Jude Medical, whose headquarters are based in St. Paul, Minn.
Larsson suffered from a life-threatening heart condition and in the autumn of 1958, when he was 43 years old, his condition became critical. His heartbeat reduced to 20 beats per minute (a healthy heart beats 60-100 times per minute) and he was afflicted by frequent fainting spells, called Stokes-Adams syndrome. His condition was so life-threatening that his wife urged his physician, in a last attempt to save his life, to expedite the process of implanting the first pacemaker. The pacemaker was surgically implanted by Åke Senning, M.D., at the Karolinska Hospital’s Heart Clinic in Stockholm.
The initial pacemaker implanted in Larsson was damaged during the operation and stopped functioning after the first night. A second identical pacemaker was surgically implanted the next day. Larsson’s life was saved, and due to the continuation of medical technology development, he lived a full and active life, using a total of 22 pacemakers during his lifetime. In 2001, he passed away at the age of 86 due to an illness unrelated to cardiac health; he outlived both the inventor, and the implanting physician, of the first implanted pacemaker.
The first implantable pacemaker was about the size of a hockey puck and had just two transistors. Today’s pacemakers, which can last up to 20 years, can be as small as a half-dollar yet contain sophisticated computer technology with as many as 20 million transistors. However, today’s pacemakers are still based on the same underlying principles as the original device, invented by Dr. Elmqvist 50 years ago.
“The remarkable story of Arne Larsson and the first implantable pacemaker is a poignant reminder of how much has been accomplished in the past 50 years,” said Daniel J. Starks, chairman, president and chief executive officer of St. Jude Medical. “This milestone invention was the foundation for understanding the electrical functions of the heart, eventually saving millions of lives worldwide. Advancements in cardiac electrophysiology – which now include implanted defibrillators that protect against sudden cardiac death, and ablation therapies that stop abnormal heart rhythms – all began with the first pacing technologies.”
Modern pacemakers have many technological advancements, and St. Jude Medical continues to focus on advancing the practice of medicine by developing medical technology and services that provide physicians with more control and contribute to successful patient outcomes. Today, St. Jude Medical pacemakers offer numerous advanced features. These pacemakers:
- Automatically self-adjust the energy output required to pace the heart per the needs of each individual patient; this optimizes battery life.
- Actively monitor the heart on a beat-by-beat basis to provide pacing only when needed, allowing the patient’s own heart rhythm to prevail whenever possible; studies have shown this is beneficial to patients’ cardiac health.
- Allow physicians to quickly program the device's timing cycles to deliver optimal therapy to patients. QuickOpt® Timing Cycle Optimization takes about 90 seconds, while the traditional means of optimizing the device (echocardiography) takes between 30 and 120 minutes.
The 50th anniversary of the implantable pacemaker was celebrated today with an event at the Swedish office of St. Jude Medical, where a newly created scholarship was presented to promote important future medical technology innovations. At the event, Göran Hägglund, Minister for Health and Social Affairs, spoke regarding Swedish medical care and research, and a panel including Harriet Wallberg-Henriksson and Peter Gudmundsson, presidents at Karolinska Institute and KTH (Royal Institute of Technology), respectively, discussed the outlook for Sweden’s role as a successful country within the medical technology field.
The anniversary also is being celebrated at the American Swedish Institute in Minneapolis with an exhibit, A Heartfelt Swedish Invention at 50 Years: The Implantable Pacemaker. The exhibit will be open to the public through Oct. 26. The exhibit features hands-on displays of medical equipment – including a model of the first pacemaker – as well as video, photographs, stories and a historical timeline of cardiac pacing.
About St. Jude Medical
St. Jude Medical develops medical technology and services that focus on putting more control into the hands of those who treat cardiac, neurological and chronic pain patients worldwide. The company is dedicated to advancing the practice of medicine by reducing risk wherever possible and contributing to successful outcomes for every patient. Headquartered in St. Paul, Minn., St. Jude Medical employs more than 12,500 people worldwide and has five major focus areas that include: cardiac rhythm management, atrial fibrillation, cardiac surgery, cardiology and neuromodulation. For more information, please visit www.sjm.com.
This news release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 that involve risks and uncertainties. Such forward-looking statements include the expectations, plans and prospects for the Company, including potential clinical successes, anticipated regulatory approvals and future product launches, and projected revenues, margins, earnings, and market shares. The statements made by the Company are based upon management’s current expectations and are subject to certain risks and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. These risks and uncertainties include market conditions and other factors beyond the Company’s control and the risk factors and other cautionary statements described in the Company’s filings with the SEC, including those described in the Risk Factors and Cautionary Statements sections of the Company’s Annual Report on Form 10-K filed on February 27, 2008. The Company does not intend to update these statements and undertakes no duty to any person to provide any such update under any circumstance.
Source: St. Jude Medical
Issuer of this News Release is solely responsible for its
Please address inquiries directly to the issuing company.